Annals of Surgical Oncology

, Volume 15, Issue 7, pp 1820–1827 | Cite as

Survival After Resection of Ampullary Carcinoma: A National Population-Based Study

  • Jessica B. O’Connell
  • Melinda A. Maggard
  • Jesse ManungaJr.
  • James S. Tomlinson
  • Howard A. Reber
  • Clifford Y. Ko
  • O. Joe Hines
Healthcare Policy and Outcomes

Abstract

Background

Ampullary cancer is the second most common periampullary cancer, with a resection and survival rate more favorable than that for pancreatic cancer. However, most reports have been conducted at single institutions with small sample sizes, and results may not reflect the practices and outcomes in the community. Our objective was to complete a population-based analysis of patients undergoing resection for ampullary carcinoma and compare it with outcomes in the published literature.

Methods

Patients diagnosed with ampullary cancer reported in the Surveillance, Epidemiology, and End Results program (1988–2003) were collected. Primary outcome was survival (5-year), and secondary outcome was stage at presentation. Comparisons were made with outcomes reported in the literature (resection rate, perioperative mortality, and 5-year survival).

Results

Of the 3292 ampullary cancer patients, 1301 (40%) underwent resection. Thirty-seven percent presented with stage I tumors. Perioperative mortality (30 day) was 7.6% after resection, and 5-year survival was 36.8%. Few patients died if they survived at least 5 years. The cancer registry data showed less early stage disease, higher perioperative mortality, and lower 5-year survival compared with published reports.

Conclusions

This is the largest population-based analysis of ampullary carcinoma. Resection rates and survival at the national level are lower, in general, compared with cancer center reports, which may have implications for regionalizing these procedures. Many patients surviving at least 5 years seem to be cured by surgical resection.

Keywords

Ampullary cancer Surgical resection Population study SEER 

References

  1. 1.
    Neoptolemos JP, Talbot IC, Carr-Locke DL, et al. Treatment and outcome in 52 consecutive cases of ampullary carcinoma. Br J Surg 1987; 74:957–61PubMedCrossRefGoogle Scholar
  2. 2.
    Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225:590PubMedCrossRefGoogle Scholar
  3. 3.
    Howe JR, Klimstra DS, Moccia RD, et al. Factors predictive of survival in ampullary carcinoma. Ann Surg 1998; 228:87–94PubMedCrossRefGoogle Scholar
  4. 4.
    Duffy JP, Hines OJ, Liu JH, et al. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections. Arch Surg 2003; 138:941–50PubMedCrossRefGoogle Scholar
  5. 5.
    Bettschart V, Rahman MW, Engelken FJF, et al. Presentation, treatment and outcome in patients with ampullary tumours. Br J Surg 2004:91:1600–7PubMedCrossRefGoogle Scholar
  6. 6.
    Di Giorgio A, Alfieri S, Rotondi F, et al. Pancreatoduodenectomy for tumors of vater’s ampulla: report on 94 consecutive patients. World J Surg 2005; 29:513–8PubMedCrossRefGoogle Scholar
  7. 7.
    Brown KM, Tompkins AJ, Sherri Y, et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg 2005; 140:529–33PubMedCrossRefGoogle Scholar
  8. 8.
    Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. J Gastrointest Surg 2005; 9:1191–206PubMedCrossRefGoogle Scholar
  9. 9.
    Yoon YS, Kim SW, Park SJ, et al. Clinicopathologic analysis of early ampullary cancers with focus on the feasibility of ampullectomy. Ann Surg 2005; 242:92–100PubMedCrossRefGoogle Scholar
  10. 10.
    Kim RD, Kundhal PS, McGilvray ID, et al. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 2006; 202:112–9PubMedCrossRefGoogle Scholar
  11. 11.
    Warren KW, Choe DS, Plaza J, et al. Results of radical resection for periampullary cancer. Ann Surg 1975; 181:534–40PubMedGoogle Scholar
  12. 12.
    Nakase A, Matsumoto Y, Uchida K, et al. Surgical treatment of cancer of the pancreas and the periampulary region: cumulative results in 57 institutions in Japan. Ann Surg 1977; 185:52–7PubMedCrossRefGoogle Scholar
  13. 13.
    Hayes DH, Bolton JS, Willis GW, et al. Carcinoma of the ampulla of Vater. Ann Surg 1987; 206:572–7PubMedCrossRefGoogle Scholar
  14. 14.
    Delcore R Jr, Connor CS, Thomas JH, et al. Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg 1989; 158:593PubMedCrossRefGoogle Scholar
  15. 15.
    Monson JR, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991; 126:353–7PubMedGoogle Scholar
  16. 16.
    Allema JH, Reinders ME, van Gulik TM, et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995; 117:247–53PubMedCrossRefGoogle Scholar
  17. 17.
    Bakkevold KE, Kambestad B. Staging of carcinoma of the pancreas and ampulla of Vater: tumor (T), lymph node (N), and distant metastasis (M) as prognostic factors. Int J Pancreatol 1995; 17:249–59PubMedGoogle Scholar
  18. 18.
    Shirai Y, Tsukada K, Ohtani T, et al. Carcinoma of the pancreas and ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 1996; 61:190–4PubMedCrossRefGoogle Scholar
  19. 19.
    Kayahara M, Nagakawa T, Ohta T, et al. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997; 121:611–7PubMedCrossRefGoogle Scholar
  20. 20.
    Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227:821–31PubMedCrossRefGoogle Scholar
  21. 21.
    Beger HG, Treitschke F,Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134:526–32PubMedCrossRefGoogle Scholar
  22. 22.
    Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003; 10:1176–83PubMedCrossRefGoogle Scholar
  23. 23.
    Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov/) Public-Use Data (1973–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission
  24. 24.
    Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla Vater. Ann Surg 1935; 102:763–79PubMedCrossRefGoogle Scholar
  25. 25.
    Birkmeyer JD, Warshaw AL, Finlayson SR, et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 1999; 126:178–83PubMedGoogle Scholar
  26. 26.
    Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280:1747–51PubMedCrossRefGoogle Scholar
  27. 27.
    Morris AM, Billingsley KG, Baxter NN, et al. Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg 2004; 139:151–5PubMedCrossRefGoogle Scholar
  28. 28.
    Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol 2006; 24:413–8Google Scholar

Copyright information

© Society of Surgical Oncology 2008

Authors and Affiliations

  • Jessica B. O’Connell
    • 1
  • Melinda A. Maggard
    • 1
  • Jesse ManungaJr.
    • 1
  • James S. Tomlinson
    • 1
    • 2
  • Howard A. Reber
    • 1
  • Clifford Y. Ko
    • 1
    • 2
  • O. Joe Hines
    • 1
  1. 1.Department of SurgeryGeffen School of Medicine at UCLA, CHSLos AngelesUSA
  2. 2.Department of SurgeryGreater West Los Angeles VA Healthcare SystemLos AngelesUSA

Personalised recommendations